Athersys Announces CEO Transition
Press release content from Business Wire. The AP news staff was not involved in its creation. Athersys Announces CEO Transition CLEVELAND, Ohio--(BUSINESS WIRE)--Feb 16, 2021-- Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem ® cell therapy, today announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately. The Athersys Board has appointed William (B.J.) Lehmann, the Company’s President and Chief Opera...
University Of Chicago United States United Kingdom University Of Cape Town Western Cape South Africa
Source: apnews.com